Press Releases Oncimmune Holdings plc

Equities

Market Closed - London S.E. Other stock markets 11:35:04 2024-07-16 am EDT			5-day change	1st Jan Change
10.45 ^GBX	-0.48%		+7.18%	-58.53%

May. 21	EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss	AN
May. 21	Earnings Flash (ONC.L) ONCIMMUNE HOLDINGS Posts Fiscal H1 Revenue GBP1.2M	MT

Oncimmune Reports Robust Interim Results, Exceeding Previous Year's Revenue in Just Six Months	May. 24	AQ
Oncimmune's strategic pivot aims for robust growth in 2024	Mar. 08	AQ
Oncimmune "relaunch" already delivering results	Dec. 05	AQ
Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights	23-05-05	AQ
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference	23-04-12	AQ
Oncimmune investment "will continue to pay dividends"	23-03-02	AQ
Annual results presentation 2021	21-11-02	PU
Annual results 2021	21-11-02	PU
Annual report 2021	21-11-02	PU
Oncimmune : Interim results 2021	21-02-15	PU
Oncimmune : Interim results presentation 2021	21-02-15	PU
Oncimmune : Annual report 2020	20-11-07	PU
Oncimmune : Annual results 2020	20-11-06	PU
Oncimmune : ECLS trial shows reduction in late-stage diagnoses of lung cancer	20-08-10	AQ
University of Aberdeen: ECLS trial shows reduction in late-stage diagnoses of lung cancer	20-08-03	AQ
University of St Andrews: ECLS trial shows reduction in late-stage diagnoses of lung cancer	20-08-03	AQ
Oncimmune : ECLS trial shows reduction in late-stage diagnoses of lung cancer	20-07-31	AQ
Oncimmune : NICE concludes review of EarlyCDT Lung	20-03-17	PU
Oncimmune : Issue of Equity	20-03-13	PU
Oncimmune : PDMR / PCA Dealings	20-03-12	PU

No results for this search